组合疗法治疗慢性盆腔炎的临床效果

摘要
图/表
参考文献(25)
相关文章 (15)

全文: PDF (545 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的研究组合疗法治疗慢性盆腔炎的临床效果及预后情况。方法选取2016年11月~2017年11月就诊于承德市中医院的89例慢性盆腔炎患者为研究对象，采用随机数字表法将其分成观察组（42例）和对照组（47例）。对照组给予单纯中药灌肠治疗，观察组在此基础上采用腹针加入特定电磁波普疗、艾灸、穴位注射、刺络放血及拔血罐组合疗法治疗。治疗后观察两组患者的临床疗效、临床症状积分、炎性因子水平、生活质量及复发情况。结果观察组治疗后总有效率高于对照组（P < 0.01）；治疗后，两组患者临床症状积分均较治疗前明显降低，且观察组低于对照组（P < 0.01）；两组患者白细胞介素-2（IL-2）、白细胞介素-10（IL-10）水平均较治疗前明显升高，且观察组高于对照组（P < 0.05或P < 0.01）；两组患者肿瘤坏死因子α（TNF-α）水平明显降低，且观察组低于对照组（P < 0.05或P < 0.01），观察组患者疼痛与不适评分明显低于对照组，积极感受、睡眠状态以及总体健康评分明显高于对照组患者（P < 0.01）。治疗后随访6个月，观察组患者的复发率明显低于对照组（P < 0.05）。结论组合疗法治疗慢性盆腔炎的临床效果明显优于单纯采用中药灌肠治疗，能够较好地改善患者的临床症状，抑制炎症，提高生活质量，减少疾病复发，具有较高的临床推广价值。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	吴威柴淑慧董君伟

关键词 ：慢性盆腔炎, 组合疗法, 中医, 临床效果

Abstract：Objective To study the clinical efficacy and prognosis of combination therapy for chronic pelvic inflammatory disease. Methods From November 2016 to November 2017, 89 patients with chronic pelvic inflammatory disease who were admitted to Chengde Hospital of Traditional Chinese Medicine were enrolled. The patients were divided into observation group (42 cases) and control group (47 cases) by random number table method. The control group was treated with simple Chinese medicine enema, the observation group was treated with abdominal acupuncture plus TDP, moxibustion, acupoint injection, and hammocks collaterals bloodletting and cupping therapy in addition. The clinical efficacy, clinical symptom scores, inflammatory factor levels, quality of life, and recurrence of patients in both groups were observed after treatment. Results The total effective rate of the observation group after treatment was higher than that of the control group (P < 0.01). After treatment, the clinical symptom scores of the two groups were significantly decreased, and those of the observation group were significantly lower than the control group (P < 0.01); the levels of IL-2 and IL-10 in the two groups increased significantly, and those in the observation group were higher than the control group (P < 0.05 or P < 0.01); the levels of TNF-α in the two groups were significantly decreased, and that in the observation group was lower than the control group (P < 0.05 or P < 0.01); the pain and discomfort scores of the observation group were significantly lower than those of the control group, the positive feeling, sleep status and overall health score were significantly higher than those the control group (P < 0.01). Six months follow-up after treatment showed that the relapse rate in the observation group was significantly lower than the control group (P < 0.05). Conclusion The clinical effect of combination therapy in treating chronic pelvic inflammatory disease is better than traditional Chinese medicine enema alone. It can improve clinical symptoms, inhibit inflammation, improve quality of life, and reduce disease recurrence. It has high clinical value.

Key words： Chronic pelvic inflammatory disease Combination therapy Traditional Chinese medicine Clinical effect

基金资助:河北省承德市科学技术研究与发展计划项目（20151072）。

引用本文:

吴威柴淑慧董君伟. 组合疗法治疗慢性盆腔炎的临床效果[J]. 中国医药导报, 2018, 15(33): 68-71.
WU Wei CHAI Shuhui DONG Junwei. Clinical effect of combination therapy in the treatment of chronic pelvic inflammatory disease. 中国医药导报, 2018, 15(33): 68-71.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2018/V15/I33/68

[1] 谈勇，夏桂成，陈婕，等．国医大师夏桂成论治盆腔炎的特点探析[J].南京中医药大学学报，2017，33（6）：545-546．
[2] Price MJ，Ades AE，Welton NJ，et al. Proportion of pelvic inflammatory disease cases caused by chlamydia trachomatis：consistent picture from different methods [J]. J Infect Dis，2016，214（4）：617-624.
[3] Vanthuyne A，Pittrof R. Diagnosis and treatment of pelvic inflammatory disease [J]. Prescriber，2016，27（10）：47-50.
[4] Das BB，Ronda J，Trent M. Pelvic inflammatory disease：improving awareness，prevention，and treatment [J]. Infect Drug Resist，2016，9（15）：191-197.
[5] 陈学奇，葛蓓芬.黄芪桂枝五物汤加减治疗慢性盆腔炎经验[J].中医杂志，2016，57（24）：2139-2140.
[6] 郝霞，牛明明，郑伟，等.张氏腹三针与传统针刺治疗慢性盆腔炎的临床疗效对比分析[J].中华中医药学刊，2016， 34（8）：2016-2018.
[7] 刘敏如，谭万信．中医妇产科学[M].2版．北京：人民卫生出版社，2011：928-938．
[8] 桑海莉，贾淑华，李亚萍，等.少腹合剂配合穴位贴敷治疗湿热瘀结型慢性盆腔炎[J].中国中医基础医学杂志，2017，23（10）：1436-1438．
[9] 贾利平，刘玉珠，周小飞．中西医结合治疗慢性盆腔炎疗效观察及安全性分析[J].中华中医药学刊，2018，36（4）：939-941．
[10] Spain J，Rheinboldt M. MDCT of pelvic inflammatory disease：a review of the pathophysiology，gamut of imaging findings，and treatment [J]. Emerg Radiol，2016，24（1）：1-7.
[11] Price MJ，Ades AE，Welton NJ，et al. Pelvic inflammatory disease and salpingitis：incidence of primary and repeat episodes in England [J]. Epidemiol Infect，2017，145（1）：208-215.
[12] Paulson Q，Douglass E，Moreno A，et al. Group A streptococcal toxic shock syndrome secondary to necrotizing pelvic inflammatory disease in a postmenopausal woman [J]. IDCases，2016，5（C）：21-23.
[13] 钟紫英，方炼砂.王不留行籽压耳穴联合盆炎康复汤保留灌肠治疗脾虚湿瘀互结型盆腔炎临床观察和安全性评价[J].时珍国医国药，2016，27（10）：2453-2455．
[14] 吴丹，郭李燕，卢佩斯.针刺对急性盆腔炎患者炎性因子的影响[J].针刺研究，2018，43（1）：55-59．
[15] 马堃，罗颂平，李敏，等．中医药防治盆腔炎性疾病优势与证据研究进展[J].中国中药杂志，2017，42（8）：1449-1454.
[16] Wolff M，Balamuth F，Sampayo E，et al. Improving adolescent pelvic inflammatory disease follow-up from the emergency department：randomized controlled trial with text messages [J]. Ann Emerg Med，2016，67（5）：602-609.
[17] Brun JL，Graesslin O，Fauconnier A，et al. Updated French guidelines for diagnosis and management of pelvic inflammatory disease [J]. Int J Gynaecol Obstet，2016，134（2）：121-125.
[18] 农贤刚，程卫萍.艾灸配合川芎嗪治疗寒湿凝滞型慢性盆腔炎疗效及对CRP、IL-6和TNF-α的影响[J].中国中医基础医学杂志，2017，23（3）：387-389．
[19] 谢琼．中医灌肠疗法应用于盆腔炎患者临床治疗的效果评价[J].中国急救医学，2016，36（s1）：46-47．
[20] Rimtepathip PP，Erickson A，Katner H，et al. Disseminated histoplasmosis presenting as pelvic inflammatory disease [J]. Clin Case Rep，2016，4（1）：76-80.
[21] 叶妮，何培芝，李星子，等．经腹热敷红藤方治疗湿热型慢性盆腔炎的疗效观察[J]．辽宁中医杂志，2016，43（5）：1013-1015．
[22] 孙晓吉，吕炳涛，齐雨，等.中药择时灌肠治疗慢性盆腔炎疗效观察[J].辽宁中医杂志，2016，43（2）：289-291．
[23] Taylor BD，Zheng X，Darville T，et al. Whole-exome sequencing to identify novel biological pathways associated with infertility after pelvic inflammatory disease [J]. Sex Transm Dis，2017，44（1）：35-41.
[24] 杨晓梅，张君探．神经肌肉刺激联合中药红子汤灌肠治疗慢性盆腔炎性不孕症效果观察[J].山东医药，2017， 57（14）：91-93．
[25] Kouijzer IJ，Polderman FN，Bekers EM，et al. Initially unrecognised group A streptococcal pelvic inflammatory disease in a postmenopausal woman [J]. Neth J Med，2018，72（9）：494-496.